ArticlebioRxiv : the preprint server for biology2025
Cargo recognition of Nesprin-2 by the dynein adapter Bicaudal D2 for a nuclear positioning pathway that is important for neuronal migration.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
8 authors.
Funding
Abstract
Nesprin-2 is a subunit of LINC complexes, which span the nuclear envelope and have key roles in mechanotransduction and nuclear positioning during brain and muscle development. Nesprin-2 interacts with the plus-end directed motor kinesin-1 and the dynein adapter Bicaudal D2 (BicD2), which in turn recruits the minus-end directed motor cytoplasmic dynein to position the nucleus during neuronal migration of postmitotic neurons, but the molecular details of these interactions are elusive. Here we present a structural model of a minimal Nesprin-2/BicD2 complex. A structure prediction with a PAE score in the high confidence range was obtained from AlphaFold and experimentally validated by mutagenesis, binding assays and biophysical studies. The core of the binding site is formed by spectrin repeats of Nesprin-2, which form an alpha-helical bundle with the cargo-binding domain of BicD2. The minimal Nesprin-2 fragment also interacts robustly with full-length BicD2. The BicD2-binding site is separated by a ∼65 residue intrinsically disordered linker from the LEWD sequence motif, that acts as kinesin-1 recruitment site, and we propose that both kinesin-1 and BicD2/dynein interact with Nesprin-2 simultaneously. We propose that structurally distinct interactions between BicD2 and its cargo adapters Nesprin-2, Nup358 and Rab6, as well as distinctions in the adjacent kinesin-1 recruiting sites could finetune overall motility for these transport pathways that have important roles in brain and muscle development. Mutations of Nesprin-2 and BicD2 cause devastating brain and muscle developmental diseases, including Emery-Dreifuss Muscular Dystrophy and spinal muscular atrophy, and results may help devise therapies for these diseases.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.